Blonder Tongue Laboratories, Inc.
BDRL
$0.149
-$0.039-20.75%
| Weiss Ratings | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.63 | |||
| Price History | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 107.25% | |||
| 30-Day Total Return | 81.82% | |||
| 60-Day Total Return | 66.67% | |||
| 90-Day Total Return | 73.91% | |||
| Year to Date Total Return | 83.49% | |||
| 1-Year Total Return | -10.11% | |||
| 2-Year Total Return | -69.97% | |||
| 3-Year Total Return | -81.48% | |||
| 5-Year Total Return | -79.70% | |||
| 52-Week High % Change | -35.40% | |||
| 52-Week Low % Change | 212.81% | |||
| Price | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.29 | |||
| 52-Week Low Price | $0.06 | |||
| 52-Week Low Price (Date) | Oct 23, 2023 | |||
| 52-Week High Price (Date) | May 09, 2023 | |||
| Valuation | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.45M | |||
| Enterprise Value | 12.17M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.22 | |||
| Earnings Per Share Growth | 527.17% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.07 | |||
| Price/Book (Q) | 1.24 | |||
| Enterprise Value/Revenue (TTM) | 0.74 | |||
| Price | $0.20 | |||
| Enterprise Value/EBITDA (TTM) | -6.70 | |||
| Enterprise Value/EBIT | -6.30 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 13.35M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 732 679 4000 | |||
| Address | One Jake Brown Road Old Bridge, NJ 08857 | |||
| Website | www.blondertongue.com | |||
| Country | United States | |||
| Year Founded | 1950 | |||
| Profitability | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -11.76% | |||
| Profit Margin | -16.12% | |||
| Management Effectiveness | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -9.90% | |||
| Return on Equity | -- | |||
| Income Statement | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 18.12M | |||
| Total Revenue (TTM) | 18.12M | |||
| Revenue Per Share | $1.36 | |||
| Gross Profit (TTM) | 5.46M | |||
| EBITDA (TTM) | -2.01M | |||
| EBIT (TTM) | -2.13M | |||
| Net Income (TTM) | -2.92M | |||
| Net Income Avl. to Common (TTM) | -2.92M | |||
| Total Revenue Growth (Q YOY) | 32.18% | |||
| Earnings Growth (Q YOY) | 109.71% | |||
| EPS Diluted (TTM) | -0.22 | |||
| EPS Diluted Growth (Q YOY) | 107.49% | |||
| Balance Sheet | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 79.00K | |||
| Cash Per Share (Q) | $0.01 | |||
| Total Current Assets (Q) | 7.97M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.07M | |||
| Current Ratio (Q) | 0.977 | |||
| Book Value Per Share (Q) | $0.08 | |||
| Total Assets (Q) | 15.01M | |||
| Total Current Liabilities (Q) | 8.16M | |||
| Total Debt (Q) | 10.80M | |||
| Total Liabilities (Q) | 13.93M | |||
| Total Common Equity (Q) | 1.07M | |||
| Cash Flow | BDRL - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -55.00K | |||
| Cash from Financing (TTM) | 1.24M | |||
| Net Change in Cash (TTM) | -195.00K | |||
| Levered Free Cash Flow (TTM) | -831.60K | |||
| Cash from Operations (TTM) | -1.38M | |||
